Tyrosine kinases enhance the function of glycine receptors in rat hippocampal neurons and human α1β glycine receptors

被引:23
作者
Caraiscos, VB
Mihic, SJ
MacDonald, JF
Orser, BA
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Anesthesia, Toronto, ON M5S 1A8, Canada
[4] Univ Texas, Neurobiol Sect, Austin, TX 78712 USA
[5] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
[6] Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Anesthesia, Toronto, ON M4N 3M5, Canada
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2002年 / 539卷 / 02期
关键词
D O I
10.1113/jphysiol.2001.013508
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glycine receptors (GlyRs) are transmitter-gated channels that mediate fast inhibitory neuro-transmission in the spinal cord and brain. The GlyR beta subunit contains a putative tyrosine phosphorylation site whose functional role has not been determined. To examine if protein tyrosine kinases (PTKs) regulate the function of GlyRs, we analysed whole-cell currents activated by applications of glycine to CA1 hippocampal neurons and spinal neurons. The role of a putative site for tyrosine phosphorylation at position 413 of the beta subunit was examined using site-directed mutagenesis and expression of recombinant (alpha(1)Beta(Y413F)) receptors in human embryonic kidney (HEK 293) cells. Lavendustin A, an inhibitor of PTKs, depressed glycine-evoked currents (I-Gly) in CA1 neurons and spinal neurons by 31 % and 40 %, respectively. In contrast, the intracellular application of the exogenous tyrosine kinase, cSrc, enhanced I-Gly in CA1 neurons by 56 %. cSrc also accelerated GlyR desensitization and increased the potency of glycine 2-fold (control EC50 = 143 muM; cSrc EC50 = 74 muM). Exogenous cSrc, applied intracellularly, upregulated heteromeric alpha(1)beta receptors but not homomeric alpha(1) receptors. Substitution mutation of the tyrosine to phenylalanine at position beta-413 prevented this enhancement. Furthermore, a selective inhibitor of the Src family kinases, PP2, down-regulated wild-type alpha(1)beta but not alpha(1)beta(Y413F) receptors. Together, these findings indicate that GlyR function is upregulated by PTKs and this modulation is dependent on the tyrosine-413 residue of the beta subunit.
引用
收藏
页码:495 / 502
页数:8
相关论文
共 27 条
[1]   NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity [J].
Ali, DW ;
Salter, MW .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :336-342
[2]   PREVENTION OF THE CONVULSANT AND HYPERALGESIC ACTION OF STRYCHNINE BY INTRATHECAL GLYCINE AND RELATED AMINO-ACIDS [J].
BEYER, C ;
BANAS, C ;
GOMORA, P ;
KOMISARUK, BR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (01) :73-78
[3]   RESIDUES WITHIN TRANSMEMBRANE SEGMENT M2 DETERMINE CHLORIDE CONDUCTANCE OF GLYCINE RECEPTOR HOMO-OLIGOMERS AND HETEROOLIGOMERS [J].
BORMANN, J ;
RUNDSTROM, N ;
BETZ, H ;
LANGOSCH, D .
EMBO JOURNAL, 1993, 12 (10) :3729-3737
[4]   Constitutive tyrosine phosphorylation of the GABAA receptor γ2 subunit in rat brain [J].
Brandon, NJ ;
Delmas, P ;
Hill, J ;
Smart, TG ;
Moss, SJ .
NEUROPHARMACOLOGY, 2001, 41 (06) :745-752
[5]   Inhibition of GABAA receptor function by tyrosine kinase inhibitors and their inactive analogues [J].
Dunne, EL ;
Moss, SJ ;
Smart, TG .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1998, 12 (4-5) :300-310
[6]   CLONING AND EXPRESSION OF THE 58 KD-BETA SUBUNIT OF THE INHIBITORY GLYCINE RECEPTOR [J].
GRENNINGLOH, G ;
PRIBILLA, I ;
PRIOR, P ;
MULTHAUP, G ;
BEYREUTHER, K ;
TALEB, O ;
BETZ, H .
NEURON, 1990, 4 (06) :963-970
[7]   Cross-modulation of glycine-activated Cl- channels by protein kinase C and cAMP-dependent protein kinase in the rat [J].
Gu, YP ;
Huang, LYM .
JOURNAL OF PHYSIOLOGY-LONDON, 1998, 506 (02) :331-339
[8]  
Handford CA, 1996, MOL BRAIN RES, V35, P211
[9]   The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors [J].
Huang, RQ ;
Fang, MJ ;
Dillon, GH .
MOLECULAR BRAIN RESEARCH, 1999, 67 (01) :177-183
[10]   Direct inhibition of glycine receptors by genistein, a tyrosine kinase inhibitor [J].
Huang, RQ ;
Dillon, GH .
NEUROPHARMACOLOGY, 2000, 39 (11) :2195-2204